Our Partnership
Key Structures
Topics
Results & Data
News Releases
-
02 February 2023
Global Fund Praises Luxembourg’s Additional Pledge, Bringing Total Contribution …
-
01 February 2023
African Leaders Unite in Pledge to End AIDS in Children
-
15 December 2022
Global Fund Welcomes Singapore’s Return As a Donor
-
14 December 2022
Global Fund and Private Sector Partners Launch US$50 Million Catalytic Fund to A…
Opinion
-
16 December 2022
The Criminalization of Sex Work Not Only Violates Human Rights – It Adds to HIV …
-
09 December 2022
A Hotline Operator’s Tireless Efforts to Keep People on Drug Treatment Despite W…
-
01 December 2022
The Best Way to Prepare for the Next Pandemic Is Not What You Think
-
30 November 2022
World AIDS Day: How are we supposed to protect our babies?
Updates
-
18 January 2023
2023-2025 Allocations Now Available
-
16 December 2022
Global Fund appoints Marijke Wijnroks as Head of Strategic Investment and Impact…
-
16 December 2022
TERG: Thematic Evaluation of the Global Fund’s Performance in Challenging Operat…
-
08 December 2022
Updated Resources for the Next Funding Cycle
Featured
GF/B13/DP29
Approved by the Board on: 28 April 2006
Phase 2 Nigeria Grants (NGA-102-G01-H-00; NGA-102-G03-H-00)
Decision Point 1:
The Board declines to approve additional funding for the Phase 2 period of the Nigeria Grant number NGA-102-G01-H-00 (Expansion of Prevention of Mother to Child Centers of Excellence).
Decision Point 2:
The Board declines to approve additional funding for the Phase 2 period of the Nigeria Grant number NGA-102-G03-H-00 (Program for the expansion of anti-retroviral therapy in Nigeria).
The Global Fund uses cookies for anonymized statistics on website use and content performance to help us improve and adapt the website. To consent to the use of cookies, please click “Accept”. To learn more about your rights and options, please read our Privacy Statement.